StemCell Therapy

Asia-Pacific now ranks in first for the total number of trials taking place, compared to its fourth-placed ranking in 2010. Credit: Shutterstock

The Asia-Pacific region has seen a 158% increase in the number of musculoskeletal disorders trials taking place over the past decade, the largest increase for any region worldwide.

The region now ranks in first for the total number of trials taking place, compared to its fourth-placed ranking in 2010.

These figures come from GlobalDatas extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.

The Asia-Pacific region saw the biggest increase in musculoskeletal disorders related trials.

Between 2010 and 2020, there was a 158% increase in the number of trials taking place.

In 2020, the largest proportion of trials in the region took place in China with 46.5% of all trials in the region taking place there.

India and South Korea had the next largest percentage of trials taking place in the region with 19.2% and 7.3%, respectively.

The Middle East saw a 142% increase in the number of musculoskeletal disorders trials taking place.

Iran saw the largest amount of trials taking place, in 2020, at 76.1%.

Trials in Saudi Arabia and Israel also made up a large proportion of the trials taking place with 13% and 6.5%, respectively.

Africa saw a 100% increase in the number trials taking place.

Egypt, South Africa and Zimbabwe made up the most trials in the region, with 75%, 10% and 5%, respectively.

North America saw a 15% increase in musculoskeletal disorders related trials taking place.

The United States saw the largest percentage of trials taking place in the region at 87.6%.

Canada and Mexico also made up a significant proportion of the trials taking place.

Europe saw a decrease in the number of musculoskeletal disorders trials.

The region saw a 40% decrease in the number of trials.

Russia made up 10.3% the largest proportion of trials taking place in the region.

Spain and the United Kingdom also made up a large amount of the trials taking place with 9.6% and 8.9%, respectively.

South and Central America saw the biggest decrease in musculoskeletal disorders trials.

The number of trials in the region fell by 50% between 2010 and 2020.

Brazil saw the largest percentage of trials taking place in the region with 50%.

Aseptic Process Solutions for the Pharmaceutical Industry

Aseptic Process Solutions for the Pharmaceutical Industry

28 Aug 2020

Original post:
A cloudy day in paradise for pharma tax havens in Cayman Islands & Bermuda? Impact of OECD tax deal on pharma in Cayman Islands and Bermuda tax...

This entry was posted on January 1, 2022 at 1:50 am and is filed under Stem Cell Panama. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |